PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · Real-Time Price · USD

1.155

+0.075 (6.94%)

At close: Apr 2, 2025, 4:00 PM

1.144

-0.011 (-0.95%)

After-hours: Apr 2, 2025, 7:55 PM EDT

PDS Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Net Income	-	-42.94	-40.85	-16.92	-14.85	Upgrade
Depreciation & Amortization	-	0.06	0.05	0.01	0.02	Upgrade
Other Amortization	-	0.65	0.18	-	-	Upgrade
Stock-Based Compensation	-	7.61	5.2	4.07	0.43	Upgrade
Other Operating Activities	-	1.18	5.24	0.28	0.18	Upgrade
Change in Accounts Payable	-	5.76	-0.09	-0.11	0.22	Upgrade
Change in Other Net Operating Assets	-	-5.96	4.57	0.18	0.85	Upgrade
Operating Cash Flow	-	-33.64	-25.71	-12.49	-13.15	Upgrade
Long-Term Debt Issued	-	-	25	-	-	Upgrade
Long-Term Debt Repaid	-	-0.06	-	-	-	Upgrade
Net Debt Issued (Repaid)	-	-0.06	25	-	-	Upgrade
Issuance of Common Stock	-	16.44	10.01	48.89	29.83	Upgrade
Repurchase of Common Stock	-	-	-0.27	-	-	Upgrade
Other Financing Activities	-	-	-0.45	-	-	Upgrade
Financing Cash Flow	-	16.38	34.29	48.89	29.83	Upgrade
Net Cash Flow	-	-17.26	8.58	36.4	16.68	Upgrade
Free Cash Flow	-	-33.64	-25.71	-12.49	-13.15	Upgrade
Free Cash Flow Per Share	-	-1.09	-0.90	-0.49	-0.79	Upgrade
Cash Interest Paid	-	3.54	0.85	-	-	Upgrade
Levered Free Cash Flow	-	-21.17	-16.47	-9.04	-7.68	Upgrade
Unlevered Free Cash Flow	-	-19.19	-15.83	-9.04	-7.68	Upgrade
Change in Net Working Capital	-	-0.04	-4.97	-0.25	-1.17	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q